US5776906A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Method for promoting fat-degradation in fat cells
Assignee: DIRECTOR GENERAL OF SHIKOKU NATIONAL AGRICULTURAL EXPERIMENT STATION MINISTRY OF AGRICULTURE FORESTRY AND FISHERIES
•
Filing: 1996-11-22
•
Granted: 1998-07-07
•
Expires: 2016-11-22
Abstract
Abstract For the purpose of providing a composition having an ability of promoting degradation of accumulated cellular fats, a substance having such ability was developed from naturally-occurring safe materials. Thus, according to the present invention, a composition for promoting fat-degradation in a fat cell comprising containing an isoflavone in an amount effective to promote the fat-degradation in said fat cell.
Inventors
- 👤 Keizo Sekiya
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-09 17:03
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/33; A61K31/335; A61K31/35; A61K31/352; A61K8/00; A61K8/18; A61K8/30; A61K8/49; A61K8/4973; A61K8/498; A61K8/60; A61K8/602; A61P; A61P3/00; A61P3/04; A61P3/06; A61P43/00; A61Q; A61Q19/00; A61Q19/06
Claims Analysis
Total Claims: 7
Claim 1
Independent Claim
35 words
A method for promoting fat degradation in a fat cell comprising the step of administering to a human a composition containing an effective amount of an isoflavone, thereby promoting fat degradation in the fat cell.
Claim 2
Independent Claim
35 words
A method for promoting fat degradation in a fat cell comprising the step of administering to a human a composition containing an effective amount of an isoflavone, thereby promoting fat degradation in the fat cell.
Claim 3
Dependent Claim
22 words
The method of claim 1, wherein the composition is in the form of a solid, a liquid, a powder, or a paste.
Claim 4
Dependent Claim
18 words
The method of claim 1, wherein the composition further contains a bulking agent, a stabilizer, or an excipient.
Claim 5
Dependent Claim
14 words
The method of claim 1, wherein the isoflavone is daidzein, daidzin, genistein, or genistin.
Claim 6
Dependent Claim
13 words
The method of claim 1, wherein the composition is administered orally or percutaneously.
Claim 7
Dependent Claim
14 words
The method of claim 1, wherein the composition is administered by injection or infusion.
References Cited (Backward Citations)
US5506211A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 2001-07-06 | 2002-01-05 | 2002-07-07 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2005-07-06 | 2006-01-05 | 2006-07-07 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2009-07-06 | 2010-01-05 | 2010-07-07 | $7700.00 | Window Closed / Lapsed |